View Filing Data

Print Document View Excel Document

Document and Entity Information - shares	6 Months Ended
Document and Entity Information - shares	Jun. 30, 2019	Aug. 05, 2019
Document and Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2019
Document Fiscal Year Focus	2019
Document Fiscal Period Focus	Q2
Entity Registrant Name	Aquabounty Technologies, Inc.
Entity Central Index Key	0001603978
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Entity Current Reporting Status	Yes
Entity Emerging Growth Company	true
Entity Small Business	true
Entity Shell Company	false
Entity Ex Transition Period	false
Entity Common Stock, Shares Outstanding		21,605,322

Consolidated Balance Sheets - USD ($)	Jun. 30, 2019	Dec. 31, 2018
Current assets:
Cash and cash equivalents	$ 10,400,795	$ 2,990,196
Certificate of deposit	12,866	12,361
Other receivables	109,896	115,982
Inventory	210,345	76,109
Prepaid expenses and other current assets	555,946	315,969
Total current assets	11,289,848	3,510,617
Property, plant and equipment, net	24,621,309	23,716,768
Right of use assets, net	426,735	0
Definite-lived intangible assets, net	164,440	171,292
Indefinite-lived intangible assets	191,800	191,800
Other assets	80,583	80,583
Total assets	36,774,715	27,671,060
Current liabilities:
Accounts payable and accrued liabilities	1,977,030	824,900
Other current liabilities	68,432	20,423
Current debt	139,274	71,613
Total current liabilities	2,184,736	916,936
Long-term lease obligations	384,507	0
Long-term debt	4,487,004	3,519,821
Total liabilities	7,056,247	4,436,757
Commitments and contingencies
Stockholders’ equity:
Common stock, $0.001 par value, 50,000,000 shares authorized; 21,598,555 (2018: 15,098,837) shares outstanding	21,598	15,099
Additional paid-in capital	155,803,946	142,707,957
Accumulated other comprehensive loss	(401,846)	(574,186)
Accumulated deficit	(125,705,230)	(118,914,567)
Total stockholders’ equity	29,718,468	23,234,303
Total liabilities and stockholders’ equity	$ 36,774,715	$ 27,671,060

Consolidated Balance Sheets (Parenthetical) - $ / shares	Jun. 30, 2019	Dec. 31, 2018
Statement of Financial Position [Abstract]
Common stock, par value (in dollars per share)	$ 0.001	$ 0.001
Common stock, share authorized (in shares)	50,000,000	50,000,000
Common stock, shares outstanding (in shares)	21,598,555	15,098,837

Consolidated Statements of Operations and Comprehensive Loss - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018
Revenues
Product revenues	$ 42,486	$ 47,898	$ 140,371	$ 66,995
Costs and expenses
Product costs	38,992	47,287	120,605	63,519
Sales and marketing	103,390	76,381	175,381	158,028
Research and development	813,449	880,822	1,476,930	1,858,639
General and administrative	3,106,374	1,827,991	5,142,868	3,214,864
Total costs and expenses	4,062,205	2,832,481	6,915,784	5,295,050
Operating loss	(4,019,719)	(2,784,583)	(6,775,413)	(5,228,055)
Other income (expense)
Gain on disposal of equipment	8,548	10,585	8,548	11,745
Interest expense	(14,212)	(5,283)	(27,550)	(10,685)
Other income (expense), net	(1,348)	(1,868)	3,752	(3,941)
Total other income (expense)	(7,012)	3,434	(15,250)	(2,881)
Net loss	(4,026,731)	(2,781,149)	(6,790,663)	(5,230,936)
Other comprehensive income (loss):
Foreign currency translation income (loss)	84,788	(85,811)	172,340	(197,929)
Total other comprehensive income (loss)	84,788	(85,811)	172,340	(197,929)
Comprehensive loss	$ (3,941,943)	$ (2,866,960)	$ (6,618,323)	$ (5,428,865)
Basic and diluted net loss per share (in dollars per share)	$ (0.19)	$ (0.22)	$ (0.37)	$ (0.42)
Weighted average number of common shares - basic and diluted (in shares)	21,313,055	12,787,761	18,515,907	12,366,657

Consolidated Statements of Changes in Stockholders' Equity - USD ($)	Total	Common Stock	Additional paid-in capital	Accumulated other comprehensive loss	Accumulated deficit
Beginning Balance, issued and outstanding (in shares) at Dec. 31, 2017		8,895,094
Beginning Balance at Dec. 31, 2017	$ 17,980,689	$ 8,895	$ 126,718,186	$ (213,884)	$ (108,532,508)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(2,449,787)				(2,449,787)
Other comprehensive income (loss)	(112,118)			(112,118)
Issuance of common stock, net of expenses (in shares)		3,692,307
Issuance of common stock, net of expenses	10,616,048	$ 3,692	10,612,356
Exercise of warrants for common stock (in shares)		76,891
Exercise of warrants for common stock	250,188	$ 77	250,111
Share based compensation (in shares)		11,151
Share based compensation	48,545	$ 11	48,534
Ending Balance, issued and outstanding (in shares) at Mar. 31, 2018		12,675,443
Ending Balance at Mar. 31, 2018	26,333,565	$ 12,675	137,629,187	(326,002)	(110,982,295)
Beginning Balance, issued and outstanding (in shares) at Dec. 31, 2017		8,895,094
Beginning Balance at Dec. 31, 2017	17,980,689	$ 8,895	126,718,186	(213,884)	(108,532,508)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(5,230,936)
Other comprehensive income (loss)	(197,929)
Ending Balance, issued and outstanding (in shares) at Jun. 30, 2018		12,848,286
Ending Balance at Jun. 30, 2018	24,099,889	$ 12,848	138,262,298	(411,813)	(113,763,444)
Beginning Balance, issued and outstanding (in shares) at Mar. 31, 2018		12,675,443
Beginning Balance at Mar. 31, 2018	26,333,565	$ 12,675	137,629,187	(326,002)	(110,982,295)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(2,781,149)				(2,781,149)
Other comprehensive income (loss)	(85,811)			(85,811)
Exercise of warrants for common stock (in shares)		172,843
Exercise of warrants for common stock	561,740	$ 173	561,567
Share based compensation (in shares)
Share based compensation	71,544		71,544
Ending Balance, issued and outstanding (in shares) at Jun. 30, 2018		12,848,286
Ending Balance at Jun. 30, 2018	24,099,889	$ 12,848	138,262,298	(411,813)	(113,763,444)
Beginning Balance, issued and outstanding (in shares) at Dec. 31, 2018		15,098,837
Beginning Balance at Dec. 31, 2018	23,234,303	$ 15,099	142,707,957	(574,186)	(118,914,567)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(2,763,932)				(2,763,932)
Other comprehensive income (loss)	87,552			87,552
Issuance of common stock, net of expenses (in shares)		3,345,282
Issuance of common stock, net of expenses	6,609,655	$ 3,345	6,606,310
Exercise of warrants for common stock (in shares)		76,797
Exercise of warrants for common stock	250,424	$ 77	250,347
Share based compensation (in shares)		176,561
Share based compensation	138,498	$ 176	138,322
Ending Balance, issued and outstanding (in shares) at Mar. 31, 2019		18,697,477
Ending Balance at Mar. 31, 2019	27,556,500	$ 18,697	149,702,936	(486,634)	(121,678,499)
Beginning Balance, issued and outstanding (in shares) at Dec. 31, 2018		15,098,837
Beginning Balance at Dec. 31, 2018	23,234,303	$ 15,099	142,707,957	(574,186)	(118,914,567)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(6,790,663)
Other comprehensive income (loss)	172,340
Ending Balance, issued and outstanding (in shares) at Jun. 30, 2019		21,598,555
Ending Balance at Jun. 30, 2019	29,718,468	$ 21,598	155,803,946	(401,846)	(125,705,230)
Beginning Balance, issued and outstanding (in shares) at Mar. 31, 2019		18,697,477
Beginning Balance at Mar. 31, 2019	27,556,500	$ 18,697	149,702,936	(486,634)	(121,678,499)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(4,026,731)				(4,026,731)
Other comprehensive income (loss)	84,788			84,788
Issuance of common stock, net of expenses (in shares)		2,901,078
Issuance of common stock, net of expenses	5,785,693	$ 2,901	5,782,792
Share based compensation (in shares)
Share based compensation	318,218		318,218
Ending Balance, issued and outstanding (in shares) at Jun. 30, 2019		21,598,555
Ending Balance at Jun. 30, 2019	$ 29,718,468	$ 21,598	$ 155,803,946	$ (401,846)	$ (125,705,230)

Consolidated Statements of Cash Flows - USD ($)	6 Months Ended
Consolidated Statements of Cash Flows - USD ($)	Jun. 30, 2019	Jun. 30, 2018
Operating activities
Net loss	$ (6,790,663)	$ (5,230,936)
Adjustment to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	576,596	273,646
Share-based compensation	456,716	120,089
Gain on disposal of equipment	(8,548)	(11,745)
Changes in operating assets and liabilities:
Other receivables	10,454	77,782
Inventory	(134,137)	88,656
Prepaid expenses and other assets	(238,820)	131,486
Accounts payable and accrued liabilities	922,237	(783,356)
Net cash used in operating activities	(5,206,165)	(5,334,378)
Investing activities
Purchase of property, plant and equipment	(925,617)	(3,039,177)
Proceeds on sale of equipment	8,548	21,745
Net cash used in investing activities	(917,069)	(3,017,432)
Financing activities
Proceeds from issuance of debt	900,767	0
Repayment of term debt	(27,837)	(28,870)
Proceeds from the issuance of common stock and warrants, net	12,395,348	10,616,048
Proceeds from the exercise of stock options and warrants, net	250,424	811,928
Net cash provided by financing activities	13,518,702	11,399,106
Effect of exchange rate changes on cash and cash equivalents	15,131	(21,351)
Net change in cash and cash equivalents	7,410,599	3,025,945
Cash and cash equivalents at beginning of period	2,990,196	492,861
Cash and cash equivalents at the end of period	10,400,795	3,518,806
Supplemental disclosure of cash flow information and non-cash transactions:
Interest paid in cash	27,550	10,685
Property and equipment included in accounts payable and accrued liabilities	422,808	330,136
Acquisition of equipment under debt arrangement	$ 0	$ 75,124

Nature of business and organization	6 Months Ended
Nature of business and organization	Jun. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of business and organization	Nature of business and organization AquaBounty Technologies, Inc. (the “Parent” and, together with its subsidiaries, the “Company”) was incorporated in December 1991 in the State of Delaware for the purpose of conducting research and development of the commercial viability of a group of proteins commonly known as antifreeze proteins. In 1996, the Parent obtained the exclusive licensing rights for a gene construct (transgene) used to create a breed of farm‑raised Atlantic salmon that exhibit growth rates that are substantially faster than traditional salmon. In 2015, the Parent obtained approval from the US Food and Drug Administration (the “FDA”) for the production, sale, and consumption of its AquAdvantage Salmon product in the United States. In 2016, the Parent obtained approval from Health Canada for the sale and consumption of its AquAdvantage Salmon product in Canada. Previously, in 2013, the Parent obtained approval from Environment Canada for the production of the product. AQUA Bounty Canada Inc. (the “Canadian Subsidiary”) was incorporated in January 1994 for the purpose of establishing a commercial biotechnology laboratory to conduct research and development programs related to the Parent’s technologies and to commercialize the Parent’s products in Canada. AquaBounty Panama, S. de R.L. (the “Panama Subsidiary”) was incorporated in May 2008 in Panama for the purpose of conducting commercial trials of the Parent’s products. With the regulatory approval of the Company’s farms in Indiana and Rollo Bay, the site in Panama was no longer needed for commercial trials. Operations at the site ceased in May 2019. AquaBounty Farms, Inc. (the “U.S. Subsidiary”) was incorporated in December 2014 in the State of Delaware for the purpose of conducting field trials and commercializing the Parent’s products in the United States. AquaBounty Farms Indiana LLC (the “Indiana Subsidiary”), which is wholly owned by the U.S. Subsidiary, was formed in June 2017 in the State of Delaware for the purpose of operating its aquaculture facility in Albany, Indiana. AquaBounty Brasil Participações Ltda. (the “Brazil Subsidiary”) was incorporated in May 2015 for the purpose of conducting field trials and commercializing the Parent’s products in Brazil.

Basis of presentation	6 Months Ended
Basis of presentation	Jun. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of presentation	Basis of presentation The unaudited interim consolidated financial statements include the accounts of AquaBounty Technologies, Inc. and its wholly owned direct subsidiaries, AQUA Bounty Canada Inc.; AquaBounty Panama, S. de R.L.; AquaBounty Farms, Inc.; AquaBounty Farms Indiana LLC; and AquaBounty Brasil Participações Ltda. All inter-company transactions and balances have been eliminated upon consolidation. The unaudited interim consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States (“GAAP”) consistent with those applied in, and should be read in conjunction with, the Company’s audited financial statements and related footnotes for the year ended December 31, 2018. The unaudited interim consolidated financial statements reflect all adjustments, consisting only of normal recurring adjustments, which are, in the opinion of management, necessary for a fair presentation of the Company’s financial position as of June 30, 2019, and its results of operations and cash flows for the interim periods presented and are not necessarily indicative of results for subsequent interim periods or for the full year. The unaudited interim consolidated financial statements do not include all of the information and footnotes required by GAAP for complete financial statements, as allowed by the relevant SEC rules and regulations; however, the Company believes that its disclosures are adequate to ensure that the information presented is not misleading. Liquidity and Management’s Plan In the Company’s Annual Report on Form 10‑K for December 31, 2018, management stated that there was substantial doubt about the Company’s ability to continue as a going concern due to its limited capital resources, and the Company’s independent registered public accounting firm emphasized this matter in its report to the shareholders and the Board of Directors. At that time, management prepared a plan to mitigate this doubt, which was implemented during the current period. At June 30, 2019, the Company’s cash balance totaled $10.4 million. We have evaluated our cash resources in view of our planned spending for ongoing operations, capital expenditures, and working capital for the next twelve months from the filing date and have determined that, while our current funds are sufficient for our cash requirements during that period, we anticipate the need to raise additional capital to fund our subsequent cash requirements and any additional projects. Accordingly, we plan to seek additional financing in the form of equity or debt, partnerships or other non-dilutive transactions to fund our cash requirements and any additional projects. Management’s assessment is based primarily on its ability and past experience in managing expenditures in order to conserve the Company’s cash. Management has the ability to reduce expenditures and slow down or delay capital spending in order to ensure its cash will extend through the next twelve months. Net loss per share Basic and diluted net loss per share available to common stockholders has been calculated by dividing net loss by the weighted average number of common shares outstanding during the period. Basic net loss is based solely on the number of Common Shares outstanding during the period. Fully diluted net loss per share includes the number of shares of common stock issuable upon the exercise of warrants and options with an exercise price less than the fair value of the common stock. Since the Company is reporting a net loss for all periods presented, all potential common shares are considered anti‑dilutive and are excluded from the calculation of diluted net loss per share. Accounting Pronouncements In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) 2016‑02, “Leases,” which requires a lessee to recognize lease liabilities for the lessee’s obligation to make lease payments arising from a lease, measured on a discounted basis, and right-of-use assets, representing the lessee’s right to use, or control the use of, specified assets for the lease term. The ASU is effective for fiscal years beginning after December 15, 2018. We adopted the ASU January 1, 2019, and, based on our current portfolio of leases, approximately $427 thousand and $445 thousand of lease assets and liabilities, respectively, are recognized on our balance sheet at June 30, 2019, primarily relating to real estate. Management does not expect any recently issued, but not yet effective, accounting standards to have a material effect on its results of operations or financial condition.

Risks and uncertainties	6 Months Ended
Risks and uncertainties	Jun. 30, 2019
Risks and Uncertainties [Abstract]
Risks and uncertainties	Risks and uncertainties The Company is subject to risks and uncertainties common in the biotechnology and aquaculture industries. Such risks and uncertainties include, but are not limited to: (i) results from current and planned product development studies and trials; (ii) decisions made by the FDA or similar regulatory bodies in other countries with respect to approval and commercial sale of any of the Company’s proposed products; (iii) the commercial acceptance of any products approved for sale and the Company’s ability to manufacture, distribute, and sell for a profit any products approved for sale; (iv) the Company’s ability to obtain the necessary patents and proprietary rights to effectively protect its technologies; and (v) the outcome of any collaborations or alliances entered into by the Company. In addition, as disclosed in “Item 1A. Risk Factors,” below, and in “Item 1A. Risk Factors” in our Annual Report on Form 10‑K for the year ended December 31, 2018, which was filed on March 7, 2019, there are a number of other risks and uncertainties that may have a material effect on the operating results of our business and our financial condition. Concentration of credit risk Financial instruments that potentially subject the Company to credit risk consist principally of cash and cash equivalents and certificates of deposit. This risk is minimized by the Company’s policy of investing in financial instruments with short-term maturities issued by highly rated financial institutions. The Company’s cash balances may at times exceed insurance limitations. The Company holds cash balances in bank accounts located in Canada to fund its local operations. These amounts are subject to foreign currency exchange risk, which is mitigated by the Company’s policy to limit the balances held in these accounts. Balances in Canadian bank accounts totaled $192,946 at June 30, 2019.

Inventory

6 Months Ended

Jun. 30, 2019

Inventory Disclosure [Abstract]

Inventory

Major classifications of inventory are summarized as follows:



	June 30,		December 31,
	2019		2018
Feed	$	92,964	$	24,288
Eggs	28,261		—
Packaging	—		8,913
Fish in process	89,120		42,908
Total inventory	$	210,345	$	76,109

Property, plant and equipment

6 Months Ended

Jun. 30, 2019

Property, Plant and Equipment [Abstract]

Property, plant and equipment

Major classifications of property, plant and equipment are summarized as follows:



	June 30,			December 31,
	2019			2018
Land	$	716,858		$	704,567
Building and improvements	9,722,264			9,244,737
Construction in process	6,966,164			6,091,265
Equipment	9,879,790			9,713,030
Office furniture and equipment	201,594			192,606
Vehicles	27,929			26,832
Total property and equipment	$	27,514,599		$	25,973,037
Less accumulated depreciation and amortization	(2,893,290		)	(2,256,269		)
Property, plant and equipment, net	$	24,621,309		$	23,716,768

Included in construction in process is $6.6 million for construction costs incurred at our Rollo Bay farm site. An additional $685 thousand has been committed.

Accounts payable and accrued liabilities

6 Months Ended

Jun. 30, 2019

Payables and Accruals [Abstract]

Accounts payable and accrued liabilities

Accounts payable and accrued liabilities include the following:



	June 30,		December 31,
	2019		2018
Accounts payable	$	1,095,940	$	366,917
Accrued compensation	557,302		223,481
Accrued professional fees and research costs	206,107		185,992
Accrued franchise and excise taxes	69,666		23,678
Accrued construction costs	40,615		13,716
Accrued other	7,400		11,116
Accounts payable and accrued liabilities	$	1,977,030	$	824,900

Debt

6 Months Ended

Jun. 30, 2019

Debt Disclosure [Abstract]

Debt

The current material terms and conditions of debt outstanding are as follows:



Original loan amount	Interest rate	Monthly repayment	Maturity date	June 30, 2019			December 31, 2018
ACOA AIF grant (C$2,871,919)	0%	Royalties	-	$	2,192,997		$	2,106,840
ACOA term loan (C$337,000)	0%	C$3,120	June 2026	197,772			203,735
ACOA term loan (C$500,000)	0%	C$4,630	November 2028	381,800			—
Kubota Canada Ltd. (C$95,961)	0%	C$1,142	January 2025	58,446			61,178
Finance PEI term loan (C$2,717,093)	4%	C$16,313	November 2023	1,795,263			1,219,681
Total debt				$	4,626,278		$	3,591,434
less: current portion				(139,274		)	(71,613		)
Long-term debt				$	4,487,004		$	3,519,821

Estimated principal payments remaining on loan debt are as follows:



Year	AIF		ACOA		FPEI		Kubota		Total
2019	$	—	$	14,295	$	39,059	$	5,234	$	58,588
2020	—		71,015		80,695		10,468		162,178
2021	—		71,015		83,988		10,468		165,471
2022	—		71,015		87,410		10,468		168,893
2023	—		71,015		1,504,111		10,468		1,585,594
Thereafter	2,192,997		281,217		—		11,340		2,485,554
Total	$	2,192,997	$	579,572	$	1,795,263	$	58,446	$	4,626,278

On March 7, 2019, the Canadian Subsidiary received C$500 thousand under a credit facility with the Atlantic Canada Opportunities Agency (“ACOA”). The proceeds of the loan are to be used to partially finance the construction at the Rollo Bay site. The loan will be repaid over a term of nine years and has a zero percent interest rate.

In 2018, the Canadian Subsidiary obtained a new loan from Finance PEI (“FPEI”), which incorporated the existing loan and provides C$2.0 million ($1.5 million) of additional funds. As of December 31, 2018, C$1.0 million ($734 thousand) had been drawn down. On May 17, 2019, an additional C$700 thousand ($535 thousand) had been drawn down. The final C$300 thousand ($230 thousand) will be drawn down during the third quarter of 2019 and payments commenced in June 2019. The loan has an interest rate of 4% and is collateralized by a mortgage executed by the Canadian Subsidiary, which conveys a first security interest in all of its current and acquired assets. The loan is guaranteed by the Parent.

Other than these loans, there have been no material changes to the Company’s debt arrangements as disclosed in our annual report on Form 10‑K for the year ended December 31, 2018.

The Company recognized interest expense of $26,531 and $10,613 for the six months ended June 30, 2019 and 2018, respectively, on its interest-bearing debt.

Leases Leases

6 Months Ended

Jun. 30, 2019

Leases [Abstract]

Leases

The Company leases certain facilities, property, and equipment under noncancelable operating leases. A determination is made if an arrangement is a lease at its inception, and leases with an initial term of twelve months or less are not recorded on the balance sheet.

The Company adopted FASB ASU 2016-02 for lease accounting on January 1, 2019 and recognized a lease liability of $532 thousand and a corresponding right-of-use asset of $512 thousand. Management calculated the lease liability based on the net present value of the remaining lease payments on the date of adoption using a weighted average discount rate of 8%. As most of the Company’s leases did not provide an implicit interest rate, management used an estimated incremental borrowing rate. The adoption did not result in any cumulative-effect adjustment to beginning retained earnings.

Lease terms may include options to extend or terminate the lease when it is reasonably certain that the Company will exercise that option. For operating leases, expense is recognized on a straight-line basis over the lease term.

The Company has agreements with lease (e.g., minimum rent payments) and non-lease components (e.g., maintenance), which are generally accounted for separately. The Company has not elected the practical expedient to account for lease and non-lease components as one lease component.

Lease expense for the six months ended June 30, 2019, amounted to $99,946. The weighted average remaining lease term of the Company’s operating leases was 22.7 years as of June 30, 2019. Lease payments included in operating cash flows totaled $101,095 for the six months ended June 30, 2019.

The table below summarizes the Company’s lease obligations and remaining payments at June 30, 2019:



				June 30, 2019						January 1, 2019
	Lease Type	End Date	Remaining Years	Remaining Payments			Lease Liability			Remaining Payments			Lease Liability
Maynard Office Lease	Operating	Mar 2023	3.75	$	247,281		$	210,957		$	278,414		$	234,685
Panama Farm Lease	Operating	Apr 2019	—	—			—			60,000			59,013
Indiana Auto Lease	Operating	Feb 2021	1.67	8,420			7,757			10,842			9,897
Indiana Well Lease	Operating	Dec 2048	29.53	709,880			226,041			717,420			228,844
Total leases				$	965,581		$	444,755		$	1,066,676		$	532,439
Less: current portion				(83,896		)	(60,248		)	(142,780		)	(117,345		)
Long-term leases				$	881,685		$	384,507		$	923,896		$	415,094

Remaining payments under leases are as follows at June 30, 2019:



Year	Office		Auto		Well		Amount
2019	$	31,726	$	2,421	$	7,540	$	41,687
2020	64,637		4,842		15,532		85,011
2021	66,416		1,157		15,998		83,571
2022	67,602		—		16,478		84,080
2023	16,900		—		16,972		33,872
Thereafter	—		—		637,360		637,360
Total Lease Payments	$	247,281	$	8,420	$	709,880	$	965,581

Stockholders' equity

6 Months Ended

Jun. 30, 2019

Equity [Abstract]

Stockholders' equity

Stockholders’ equity

Recent issuances

On March 21, 2019, the Company completed a public offering of 3,345,282 Common Shares. Net proceeds to the Company were $6.6 million after deducting discounts, fees, and expenses.

On April 5, 2019, the Company completed a public offering of 2,554,590 Common Shares. Net proceeds to the Company were $5.2 million after deducting discounts, fees, and expenses.

On April 17, 2019, the Company issued 346,488 Common Shares in conjunction with the overallotment exercise by the Company’s investment banker. Net proceeds to the Company were $696 thousand after deducting discounts, fees, and expenses.

Warrants

The following table summarizes information about outstanding warrants at June 30, 2019:



	Number of warrant shares		Weighted average exercise price
Outstanding at December 31, 2018	1,745,868			$3.25
Exercised	(76,797	)	3.25
Outstanding at June 30, 2019	1,669,071			$3.25
Exercisable at June 30, 2019	1,669,071			$3.25

During the six months ended June 30, 2019, the Company issued 76,797 Common Shares at $3.25 per share in conjunction with the exercise of warrants, with total proceeds of $250 thousand.

Share-based compensation

Restricted stock

A summary of the Company’s shares of restricted stock as of June 30, 2019, is as follows:



	Shares		Weighted average grant date fair value
Balance at December 31, 2018	8,867			$3.51
Granted	176,561		2.13
Vested	(83,640	)	2.20
Balance at June 30, 2019	101,788			$2.20

During the six months ended June 30, 2019 and 2018, the Company expensed $184,316 and $13,664, respectively, related to the restricted stock awards. At June 30, 2019, the balance of unearned share-based compensation to be expensed in future periods related to the restricted stock awards is $223,017. The period over which the unearned share-based compensation is expected to be earned is approximately 2.8 years.

Stock options

The Company’s option activity is summarized as follows:



	Number of options		Weighted average exercise price
Outstanding at December 31, 2018	339,964			$7.09
Issued	278,500		2.21
Expired	(668	)	10.88
Outstanding at June 30, 2019	617,796			$4.88
Exercisable at June 30, 2019	420,959			$5.97

Unless otherwise indicated, options issued to employees, members of the Board of Directors, and non-employees are vested over one to three years and are exercisable for a term of ten years from the date of issuance.

The fair values of stock option grants to employees and members of the Board of Directors during 2019 were measured on the date of grant using Black-Scholes, with the following weighted average assumptions:



	March 2019	April 2019	June 2019
Expected volatility	89%	94%	96%
Risk free interest rate	2.53%	2.28%	1.85%
Expected dividend yield	0%	0%	0%
Expected life (in years)	5	5	5

The weighted average fair value of stock options granted during the six months ended June 30, 2019, was $2.21.

The total intrinsic value of all options outstanding was $303,780 and $0 at June 30, 2019, and December 31, 2018, respectively. The total intrinsic value of exercisable options was $139,305 and $0 at June 30, 2019, and December 31, 2018, respectively.

The following table summarizes information about options outstanding and exercisable at June 30, 2019:



Weighted average exercise price of outstanding options	Number of options outstanding	Weighted average remaining estimated life (in years)	Number of options exercisable	Weighted average exercise price of outstanding and exercisable options
$2.50 - $5.70	482,367	7.9	291,229
$6.90 - $9.60	52,841	3.2	52,841
$10.50 - $10.80	4,000	4.6	4,000
$14.20 - $23.40	78,588	6.7	72,889
	617,796		420,959	$5.97

Total share-based compensation on stock options amounted to $272,401 and $106,425 for the six months ended June 30, 2019 and 2018, respectively. At June 30, 2019, the balance of unearned share-based compensation to be expensed in future periods related to unvested share-based awards was $331,829. The period over which the unearned share-based compensation is expected to be earned is approximately 1.0 years.

During the period ended June 30, 2019, the Company recognized share based compensation of $134,258 related to the accelerated vesting and exercisable term change for options to purchase an aggregate of 153,940 shares for the Company’s former CEO, who retired June 30, 2019. Each option granted was revalued as of June 30, 2019, using the following Black-Scholes values to determine the incremental charges for the option modification: expected volatility of 97%, risk free interest rate of 1.71% to 1.92%, expected dividend yield of 0.0%, and expected life of 1.5 to 5 years.

The following table summarizes the expense related to the options revalued at June 30, 2019:



		Expense
Grant date	Number of options	Previous		Accelerated		Incremental		Total
1/11/2011	16,667	$	109,769	$	—	$	11,782	$	121,551
1/20/2014	6,667	120,712		—		7,621		128,333
2/27/2018	60,606	99,738		—		12,313		112,051
4/21/2017	20,000	70,346		20,736		13,485		104,567
4/30/2019	50,000	13,453		67,047		1,274		81,774
	153,940	$	414,018	$	87,783	$	46,475	$	548,276

Commitments and contingencies	6 Months Ended
Commitments and contingencies	Jun. 30, 2019
Commitments and Contingencies Disclosure [Abstract]
Commitments and contingencies	Commitments and contingencies The Company recognizes and discloses commitments when it enters into executed contractual obligations with other parties. The Company accrues contingent liabilities when it is probable that future expenditures will be made and such expenditures can be reasonably estimated. See Note 5 for commitments related to our renovation and construction costs. There have been no other material changes to the commitments and contingencies disclosed in our Annual Report on Form 10‑K as of and for the year ended December 31, 2018.

Related Party Collaboration Agreement	6 Months Ended
Related Party Collaboration Agreement	Jun. 30, 2019
Related Party Transactions [Abstract]
Related Party Collaboration Agreement	Related Party Collaboration Agreement In February 2013, the Company entered into an Exclusive Channel Collaboration agreement (“ECC”) with Intrexon pursuant to which the Company will use Intrexon’s UltraVector and other technology platforms to develop and commercialize additional bioengineered traits in finfish for human consumption. Total Intrexon service costs incurred under the terms of this agreement for the six months ended June 30, 2019 and 2018, amounted to $15,734 and $136,041, respectively, and are included as a component of research and development expense in our Consolidated Statements of Operations and Comprehensive Loss. For the three months ended June 30, 2019 and 2018, service costs incurred amounted to $4,924 and $44,893, respectively. Included in accounts payable and accrued liabilities at June 30, 2019, and December 31, 2018, are amounts due to Intrexon under the ECC totaling $2,594 and $800, respectively.

Basis of presentation (Policies)	6 Months Ended
Basis of presentation (Policies)	Jun. 30, 2019
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Consolidation	The unaudited interim consolidated financial statements include the accounts of AquaBounty Technologies, Inc. and its wholly owned direct subsidiaries, AQUA Bounty Canada Inc.; AquaBounty Panama, S. de R.L.; AquaBounty Farms, Inc.; AquaBounty Farms Indiana LLC; and AquaBounty Brasil Participações Ltda. All inter-company transactions and balances have been eliminated upon consolidation.
Basis of presentation	The unaudited interim consolidated financial statements have been prepared in conformity with generally accepted accounting principles in the United States (“GAAP”) consistent with those applied in, and should be read in conjunction with, the Company’s audited financial statements and related footnotes for the year ended December 31, 2018. The unaudited interim consolidated financial statements reflect all adjustments, consisting only of normal recurring adjustments, which are, in the opinion of management, necessary for a fair presentation of the Company’s financial position as of June 30, 2019, and its results of operations and cash flows for the interim periods presented and are not necessarily indicative of results for subsequent interim periods or for the full year. The unaudited interim consolidated financial statements do not include all of the information and footnotes required by GAAP for complete financial statements, as allowed by the relevant SEC rules and regulations; however, the Company believes that its disclosures are adequate to ensure that the information presented is not misleading.
Net loss per share	Basic and diluted net loss per share available to common stockholders has been calculated by dividing net loss by the weighted average number of common shares outstanding during the period. Basic net loss is based solely on the number of Common Shares outstanding during the period. Fully diluted net loss per share includes the number of shares of common stock issuable upon the exercise of warrants and options with an exercise price less than the fair value of the common stock. Since the Company is reporting a net loss for all periods presented, all potential common shares are considered anti‑dilutive and are excluded from the calculation of diluted net loss per share.
Accounting Pronouncements	In February 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standard Update (“ASU”) 2016‑02, “Leases,” which requires a lessee to recognize lease liabilities for the lessee’s obligation to make lease payments arising from a lease, measured on a discounted basis, and right-of-use assets, representing the lessee’s right to use, or control the use of, specified assets for the lease term. The ASU is effective for fiscal years beginning after December 15, 2018. We adopted the ASU January 1, 2019, and, based on our current portfolio of leases, approximately $427 thousand and $445 thousand of lease assets and liabilities, respectively, are recognized on our balance sheet at June 30, 2019, primarily relating to real estate. Management does not expect any recently issued, but not yet effective, accounting standards to have a material effect on its results of operations or financial condition.

Inventory (Tables)

6 Months Ended

Jun. 30, 2019

Inventory Disclosure [Abstract]

Major classifications of inventory

Major classifications of inventory are summarized as follows:



	June 30,		December 31,
	2019		2018
Feed	$	92,964	$	24,288
Eggs	28,261		—
Packaging	—		8,913
Fish in process	89,120		42,908
Total inventory	$	210,345	$	76,109

Property, plant and equipment (Tables)

6 Months Ended

Jun. 30, 2019

Property, Plant and Equipment [Abstract]

Major classifications of property, plant and equipment

Major classifications of property, plant and equipment are summarized as follows:



	June 30,			December 31,
	2019			2018
Land	$	716,858		$	704,567
Building and improvements	9,722,264			9,244,737
Construction in process	6,966,164			6,091,265
Equipment	9,879,790			9,713,030
Office furniture and equipment	201,594			192,606
Vehicles	27,929			26,832
Total property and equipment	$	27,514,599		$	25,973,037
Less accumulated depreciation and amortization	(2,893,290		)	(2,256,269		)
Property, plant and equipment, net	$	24,621,309		$	23,716,768

Accounts payable and accrued liabilities (Tables)

6 Months Ended

Jun. 30, 2019

Payables and Accruals [Abstract]

Schedule of accounts payable and accrued liabilities

Accounts payable and accrued liabilities include the following:



	June 30,		December 31,
	2019		2018
Accounts payable	$	1,095,940	$	366,917
Accrued compensation	557,302		223,481
Accrued professional fees and research costs	206,107		185,992
Accrued franchise and excise taxes	69,666		23,678
Accrued construction costs	40,615		13,716
Accrued other	7,400		11,116
Accounts payable and accrued liabilities	$	1,977,030	$	824,900

Debt (Tables)

6 Months Ended

Jun. 30, 2019

Debt Disclosure [Abstract]

Material terms and conditions of outstanding debt

The current material terms and conditions of debt outstanding are as follows:



Original loan amount	Interest rate	Monthly repayment	Maturity date	June 30, 2019			December 31, 2018
ACOA AIF grant (C$2,871,919)	0%	Royalties	-	$	2,192,997		$	2,106,840
ACOA term loan (C$337,000)	0%	C$3,120	June 2026	197,772			203,735
ACOA term loan (C$500,000)	0%	C$4,630	November 2028	381,800			—
Kubota Canada Ltd. (C$95,961)	0%	C$1,142	January 2025	58,446			61,178
Finance PEI term loan (C$2,717,093)	4%	C$16,313	November 2023	1,795,263			1,219,681
Total debt				$	4,626,278		$	3,591,434
less: current portion				(139,274		)	(71,613		)
Long-term debt				$	4,487,004		$	3,519,821

Estimated principal payments on loan debt

Estimated principal payments remaining on loan debt are as follows:



Year	AIF		ACOA		FPEI		Kubota		Total
2019	$	—	$	14,295	$	39,059	$	5,234	$	58,588
2020	—		71,015		80,695		10,468		162,178
2021	—		71,015		83,988		10,468		165,471
2022	—		71,015		87,410		10,468		168,893
2023	—		71,015		1,504,111		10,468		1,585,594
Thereafter	2,192,997		281,217		—		11,340		2,485,554
Total	$	2,192,997	$	579,572	$	1,795,263	$	58,446	$	4,626,278

- Definition

Tabular disclosure of long-debt instruments or arrangements, including identification, terms, features, collateral requirements and other information necessary to a fair presentation. These are debt arrangements that originally required repayment more than twelve months after issuance or greater than the normal operating cycle of the entity, if longer.

+ References

Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 210
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.5-02.22)
-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 1A
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28541-108399

Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 6
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21506-112644

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08.(e),(f))
-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 5: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 45
-Paragraph 2
-URI http://asc.fasb.org/extlink&oid=114775744&loc=d3e28551-108399

Reference 6: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21521-112644

Reference 7: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21538-112644

Reference 8: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 470
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=75038535&loc=d3e64711-112823

Reference 9: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 835
-SubTopic 30
-Section 55
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=114775985&loc=d3e28878-108400

Reference 10: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 505
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109259400&loc=d3e21475-112644

+ Details

Leases Leases (Tables)

6 Months Ended

Jun. 30, 2019

Leases [Abstract]

Operating lease obligations and remaining payments

The table below summarizes the Company’s lease obligations and remaining payments at June 30, 2019:



				June 30, 2019						January 1, 2019
	Lease Type	End Date	Remaining Years	Remaining Payments			Lease Liability			Remaining Payments			Lease Liability
Maynard Office Lease	Operating	Mar 2023	3.75	$	247,281		$	210,957		$	278,414		$	234,685
Panama Farm Lease	Operating	Apr 2019	—	—			—			60,000			59,013
Indiana Auto Lease	Operating	Feb 2021	1.67	8,420			7,757			10,842			9,897
Indiana Well Lease	Operating	Dec 2048	29.53	709,880			226,041			717,420			228,844
Total leases				$	965,581		$	444,755		$	1,066,676		$	532,439
Less: current portion				(83,896		)	(60,248		)	(142,780		)	(117,345		)
Long-term leases				$	881,685		$	384,507		$	923,896		$	415,094

Remaining payments under leases

Remaining payments under leases are as follows at June 30, 2019:



Year	Office		Auto		Well		Amount
2019	$	31,726	$	2,421	$	7,540	$	41,687
2020	64,637		4,842		15,532		85,011
2021	66,416		1,157		15,998		83,571
2022	67,602		—		16,478		84,080
2023	16,900		—		16,972		33,872
Thereafter	—		—		637,360		637,360
Total Lease Payments	$	247,281	$	8,420	$	709,880	$	965,581

Stockholders' equity (Tables)

6 Months Ended

Jun. 30, 2019

Equity [Abstract]

Schedule of outstanding warrants

The following table summarizes information about outstanding warrants at June 30, 2019:



	Number of warrant shares		Weighted average exercise price
Outstanding at December 31, 2018	1,745,868			$3.25
Exercised	(76,797	)	3.25
Outstanding at June 30, 2019	1,669,071			$3.25
Exercisable at June 30, 2019	1,669,071			$3.25

Schedule of restricted stock activity

A summary of the Company’s shares of restricted stock as of June 30, 2019, is as follows:



	Shares		Weighted average grant date fair value
Balance at December 31, 2018	8,867			$3.51
Granted	176,561		2.13
Vested	(83,640	)	2.20
Balance at June 30, 2019	101,788			$2.20

Schedule of stock option activity

The Company’s option activity is summarized as follows:



	Number of options		Weighted average exercise price
Outstanding at December 31, 2018	339,964			$7.09
Issued	278,500		2.21
Expired	(668	)	10.88
Outstanding at June 30, 2019	617,796			$4.88
Exercisable at June 30, 2019	420,959			$5.97

Fair value of stock option grants



	March 2019	April 2019	June 2019
Expected volatility	89%	94%	96%
Risk free interest rate	2.53%	2.28%	1.85%
Expected dividend yield	0%	0%	0%
Expected life (in years)	5	5	5

Summary of options outstanding and exercisable

The following table summarizes information about options outstanding and exercisable at June 30, 2019:



Weighted average exercise price of outstanding options	Number of options outstanding	Weighted average remaining estimated life (in years)	Number of options exercisable	Weighted average exercise price of outstanding and exercisable options
$2.50 - $5.70	482,367	7.9	291,229
$6.90 - $9.60	52,841	3.2	52,841
$10.50 - $10.80	4,000	4.6	4,000
$14.20 - $23.40	78,588	6.7	72,889
	617,796		420,959	$5.97

Summary of expense related to options revalued

The following table summarizes the expense related to the options revalued at June 30, 2019:



		Expense
Grant date	Number of options	Previous		Accelerated		Incremental		Total
1/11/2011	16,667	$	109,769	$	—	$	11,782	$	121,551
1/20/2014	6,667	120,712		—		7,621		128,333
2/27/2018	60,606	99,738		—		12,313		112,051
4/21/2017	20,000	70,346		20,736		13,485		104,567
4/30/2019	50,000	13,453		67,047		1,274		81,774
	153,940	$	414,018	$	87,783	$	46,475	$	548,276

- Definition

Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable.

+ References + Details

Basis of presentation (Details) - USD ($)	Jun. 30, 2019	Jan. 01, 2019	Dec. 31, 2018	Jun. 30, 2018	Dec. 31, 2017
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Cash balance	$ 10,400,795		$ 2,990,196	$ 3,518,806	$ 492,861
Right of use asset	426,735	$ 512,000	$ 0
Lease liability	$ 444,755	$ 532,439

Risks and uncertainties (Details)	Jun. 30, 2019 USD ($)
Concentration of credit risk \| Cash \| Canada
Concentration Risk [Line Items]
Balance in Canadian bank accounts	$ 192,946

Inventory (Details) - USD ($)	Jun. 30, 2019	Dec. 31, 2018
Inventory [Line Items]
Inventory	$ 210,345	$ 76,109
Feed
Inventory [Line Items]
Inventory	92,964	24,288
Eggs
Inventory [Line Items]
Inventory	28,261	0
Packaging
Inventory [Line Items]
Inventory	0	8,913
Fish in process
Inventory [Line Items]
Inventory	$ 89,120	$ 42,908

Property, plant and equipment - Schedule of property, plant and equipment (Details) - USD ($)	Jun. 30, 2019	Dec. 31, 2018
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 27,514,599	$ 25,973,037
Less accumulated depreciation and amortization	(2,893,290)	(2,256,269)
Property, plant and equipment, net	24,621,309	23,716,768
Land
Property, Plant and Equipment [Line Items]
Total property and equipment	716,858	704,567
Building and improvements
Property, Plant and Equipment [Line Items]
Total property and equipment	9,722,264	9,244,737
Construction in process
Property, Plant and Equipment [Line Items]
Total property and equipment	6,966,164	6,091,265
Equipment
Property, Plant and Equipment [Line Items]
Total property and equipment	9,879,790	9,713,030
Office furniture and equipment
Property, Plant and Equipment [Line Items]
Total property and equipment	201,594	192,606
Vehicles
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 27,929	$ 26,832

Property, plant and equipment - Additional Information (Details) - USD ($)	6 Months Ended
	Jun. 30, 2019	Dec. 31, 2018
Property, Plant and Equipment [Line Items]
Construction in process	$ 27,514,599	$ 25,973,037
Capital Additions \| Rollo Bay farm site
Property, Plant and Equipment [Line Items]
Property, Plant, and equipment cost commitment	685,000
Construction in process
Property, Plant and Equipment [Line Items]
Construction in process	6,966,164	$ 6,091,265
Construction in process \| Rollo Bay farm site
Property, Plant and Equipment [Line Items]
Construction in process	$ 6,600,000

Accounts payable and accrued liabilities (Details) - USD ($)	Jun. 30, 2019	Dec. 31, 2018
Payables and Accruals [Abstract]
Accounts payable	$ 1,095,940	$ 366,917
Accrued compensation	557,302	223,481
Accrued professional fees and research costs	206,107	185,992
Accrued franchise and excise taxes	69,666	23,678
Accrued construction costs	40,615	13,716
Accrued other	7,400	11,116
Accounts payable and accrued liabilities	$ 1,977,030	$ 824,900

Debt - Schedule of Debt (Details)	6 Months Ended
Debt - Schedule of Debt (Details)	Jun. 30, 2019 CAD ($)	Jun. 30, 2019 USD ($)	Mar. 07, 2019 CAD ($)	Dec. 31, 2018 USD ($)
Debt Instrument [Line Items]
Total Debt		$ 4,626,278		$ 3,591,434
less: current portion		(139,274)		(71,613)
Long-term debt		4,487,004		3,519,821
ACOA AIF Grant (C$2,871,919)
Debt Instrument [Line Items]
Total Debt		2,192,997
Kubota Canada Ltd (C$95,961)
Debt Instrument [Line Items]
Total Debt		58,446
Finance PEI term loan (C$2,717,093)
Debt Instrument [Line Items]
Total Debt		$ 1,795,263
Government grant \| ACOA AIF Grant (C$2,871,919)
Debt Instrument [Line Items]
Original loan amount	$ 2,871,919
Interest rate	0.00%	0.00%
Total Debt		$ 2,192,997		2,106,840
Term loan \| ACOA term loan (C$337,000)
Debt Instrument [Line Items]
Original loan amount	$ 337,000
Interest rate	0.00%	0.00%
Monthly repayment	$ 3,120
Total Debt		$ 197,772		203,735
Term loan \| ACOA term loan (C$500,000)
Debt Instrument [Line Items]
Original loan amount	$ 500,000		$ 500,000
Interest rate	0.00%	0.00%
Monthly repayment	$ 4,630
Total Debt		$ 381,800		0
Term loan \| Kubota Canada Ltd (C$95,961)
Debt Instrument [Line Items]
Original loan amount	$ 95,961
Interest rate	0.00%	0.00%
Monthly repayment	$ 1,142
Total Debt		$ 58,446		61,178
Term loan \| Finance PEI term loan (C$2,717,093)
Debt Instrument [Line Items]
Original loan amount	$ 717,093
Interest rate	4.00%	4.00%
Monthly repayment	$ 16,313
Total Debt		$ 1,795,263		$ 1,219,681

Debt - Debt Maturities (Details) - USD ($)	Jun. 30, 2019	Dec. 31, 2018
Year
2019	$ 58,588
2020	162,178
2021	165,471
2022	168,893
2023	1,585,594
Thereafter	2,485,554
Total	4,626,278	$ 3,591,434
Atlantic Canada Opportunities Agency AIF Grant
Year
2019	0
2020	0
2021	0
2022	0
2023	0
Thereafter	2,192,997
Total	2,192,997
Atlantic Canada Opportunities Agency Term Loan
Year
2019	14,295
2020	71,015
2021	71,015
2022	71,015
2023	71,015
Thereafter	281,217
Total	579,572
PEI Finance Term Loan
Year
2019	39,059
2020	80,695
2021	83,988
2022	87,410
2023	1,504,111
Thereafter	0
Total	1,795,263
Kubota Canada Ltd
Year
2019	5,234
2020	10,468
2021	10,468
2022	10,468
2023	10,468
Thereafter	11,340
Total	$ 58,446

Debt - Additional Information (Details)	6 Months Ended
Debt - Additional Information (Details)	Jun. 30, 2019 USD ($)	Jun. 30, 2018 USD ($)	Jun. 30, 2019 CAD ($)	Jun. 30, 2019 USD ($)	May 17, 2019 CAD ($)	May 17, 2019 USD ($)	Mar. 07, 2019 CAD ($)	Dec. 31, 2018 CAD ($)	Dec. 31, 2018 USD ($)	Oct. 16, 2018 CAD ($)	Oct. 16, 2018 USD ($)
Debt Instrument [Line Items]
Interest expense on debt	$ 26,531	$ 10,613
Term loan \| ACOA term loan (C$500,000)
Debt Instrument [Line Items]
Original loan amount			$ 500,000				$ 500,000
Debt instrument term (in years)	9 years
Interest rate			0.00%	0.00%
Term loan \| PEI Finance Term Loan October 2018 [Member]
Debt Instrument [Line Items]
Original loan amount										$ 2,000,000	$ 1,500,000
Funds drawn on loan			$ 300,000	$ 230,000	$ 700,000	$ 535,000		$ 1,000,000	$ 734,000
Interest rate										4.00%	4.00%

Leases Lease Obligations (Details) - USD ($)	Jun. 30, 2019	Jan. 01, 2019
Remaining Years	22 years 8 months 12 days
Remaining Payments	$ 965,581	$ 1,066,676
Lease liability	444,755	532,439
Less: remaining payments, current portion	(83,896)	(142,780)
Less: lease liability, current portion	(60,248)	(117,345)
Remaining payments, long-term leases	881,685	923,896
Lease liability, long-term leases	$ 384,507	415,094
Maynard Office Lease
Remaining Years	3 years 9 months
Remaining Payments	$ 247,281	278,414
Lease liability	$ 210,957	234,685
Panama Farm Lease
Remaining Years	0 days
Remaining Payments	$ 0	60,000
Lease liability	$ 0	59,013
Indiana auto lease
Remaining Years	1 year 8 months 1 day
Remaining Payments	$ 8,420	10,842
Lease liability	$ 7,757	9,897
Indiana well lease
Remaining Years	29 years 6 months 11 days
Remaining Payments	$ 709,880	717,420
Lease liability	$ 226,041	$ 228,844

Leases Remaining Lease Payments (Details) - USD ($)	Jun. 30, 2019	Jan. 01, 2019
Lessee, Lease, Description [Line Items]
2019	$ 41,687
2020	85,011
2021	83,571
2022	84,080
2023	33,872
Thereafter	637,360
Total Lease Payments	965,581	$ 1,066,676
Office
Lessee, Lease, Description [Line Items]
2019	31,726
2020	64,637
2021	66,416
2022	67,602
2023	16,900
Thereafter	0
Total Lease Payments	247,281
Auto
Lessee, Lease, Description [Line Items]
2019	2,421
2020	4,842
2021	1,157
2022	0
2023	0
Thereafter	0
Total Lease Payments	8,420
Well
Lessee, Lease, Description [Line Items]
2019	7,540
2020	15,532
2021	15,998
2022	16,478
2023	16,972
Thereafter	637,360
Total Lease Payments	$ 709,880

Leases Additional Information (Details) - USD ($)	6 Months Ended
Leases Additional Information (Details) - USD ($)	Jun. 30, 2019	Jan. 01, 2019	Dec. 31, 2018
Additional Information [Abstract]
Lease liability	$ 384,507	$ 532,000	$ 0
Right of use asset	$ 426,735	$ 512,000	$ 0
Weighted average discount rate of remaining lease payments	8.00%
Lease expense	$ 99,946
Weighted average remaining lease term, all operating leases	22 years 8 months 12 days
Lease payments	$ 101,095

Stockholders' equity - Recent Issuances (Details) $ in Millions	1 Months Ended
	Mar. 31, 2019 USD ($) shares
March 2019 Public Offering [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Proceeds from common shares offering \| $	$ 6.6
April 2019 Public Offering [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Proceeds from common shares offering \| $	5.2
Overallotment exercise [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Proceeds from common shares offering \| $	$ 0.7
Common Stock \| March 2019 Public Offering [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Issued (in shares) \| shares	3,345,282
Common Stock \| April 2019 Public Offering [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Issued (in shares) \| shares	2,554,590
Common Stock \| Overallotment exercise [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Issued (in shares) \| shares	346,488

Stockholders' equity - Warrants (Details) - Warrant $ / shares in Units, $ in Thousands	6 Months Ended
	Jun. 30, 2019 USD ($) $ / shares shares
Number of options
Outstanding, beginning balance (in shares) \| shares	1,745,868
Exercised (in shares) \| shares	(76,797)
Outstanding, ending balance (in shares) \| shares	1,669,071
Exercisable (in shares) \| shares	1,669,071
Weighted average exercise price
Outstanding, beginning balance (in dollars per share) \| $ / shares	$ 3.25
Exercised (in dollars per share) \| $ / shares	3.25
Outstanding, ending balance (in dollars per share) \| $ / shares	3.25
Exercisable (in dollars per share) \| $ / shares	$ 3.25
Proceeds from warrant exercised \| $	$ 250

Stockholders' equity - Restricted stock activity (Details) - Restricted Stock - USD ($)	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018
Shares
Beginning balance (in shares)	8,867
Granted (in shares)	176,561
Vested (in shares)	(83,640)
Ending balance (in shares)	101,788
Weighted average grant date fair value
Beginning balance (in dollars per share)	$ 3.51
Granted (in dollars per share)	2.13
Vested (in dollars per share)	2.20
Ending balance (in dollars per share)	$ 2.20
Expense related to restricted stock awards	$ 184,316	$ 13,664
Future expected expense related to restricted stock awards	$ 223,017
Period of recognition	2 years 9 months 18 days

Stockholders' equity - Stock option activity (Details) - Employee Stock Option	6 Months Ended
	Jun. 30, 2019 $ / shares shares
Weighted average exercise price
Outstanding, beginning balance (in dollars per share) \| $ / shares	$ 7.09
Issued (in dollars per share) \| $ / shares	2.21
Expired (in dollars per share) \| $ / shares	10.88
Outstanding, ending balance (in dollars per share) \| $ / shares	4.88
Exercisable (in dollars per share) \| $ / shares	$ 5.97
Number of options
Outstanding, beginning balance (in shares) \| shares	339,964
Issued (in shares) \| shares	278,500
Expired (in shares) \| shares	(668)
Outstanding, ending balance (in shares) \| shares	617,796
Exercisable (in shares) \| shares	420,959
Stock options, exercisable term (in years)	10 years
Minimum
Number of options
Stock options, vesting period (in years)	1 year
Maximum
Number of options
Stock options, vesting period (in years)	3 years

Stockholders' equity - Weighted Average Assumptions (Details) - Employee Stock Option	1 Months Ended
	Jun. 30, 2019	Apr. 30, 2019	Mar. 31, 2019
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected volatility	96.00%	94.00%	89.00%
Risk free interest rate	1.85%	2.28%	2.53%
Expected dividend yield	0.00%	0.00%	0.00%
Expected life (in years)	5 years	5 years	5 years

Stockholders' equity - Summary of options outstanding and exercisable (Details)	6 Months Ended
	Jun. 30, 2019 $ / shares shares
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Number of options outstanding (in shares)	617,796
Number of options exercisable (in shares)	420,959
Weighted average exercise price of outstanding and exercisable options (in dollars per share) \| $ / shares	$ 5.97
$2.50 - $5.70
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Number of options outstanding (in shares)	482,367
Weighted average remaining estimated life (in years)	7 years 10 months 24 days
Number of options exercisable (in shares)	291,229
$6.90 - $9.60
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Number of options outstanding (in shares)	52,841
Weighted average remaining estimated life (in years)	3 years 2 months 12 days
Number of options exercisable (in shares)	52,841
$10.50 - $10.80
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Number of options outstanding (in shares)	4,000
Weighted average remaining estimated life (in years)	4 years 7 months 6 days
Number of options exercisable (in shares)	4,000
$14.20 - $23.40
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Number of options outstanding (in shares)	78,588
Weighted average remaining estimated life (in years)	6 years 8 months 12 days
Number of options exercisable (in shares)	72,889
Minimum \| $2.50 - $5.70
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Weighted average price of outstanding options (in dollars per share) \| $ / shares	$ 2.50
Minimum \| $6.90 - $9.60
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Weighted average price of outstanding options (in dollars per share) \| $ / shares	6.90
Minimum \| $10.50 - $10.80
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Weighted average price of outstanding options (in dollars per share) \| $ / shares	10.50
Minimum \| $14.20 - $23.40
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Weighted average price of outstanding options (in dollars per share) \| $ / shares	14.20
Maximum \| $2.50 - $5.70
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Weighted average price of outstanding options (in dollars per share) \| $ / shares	5.70
Maximum \| $6.90 - $9.60
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Weighted average price of outstanding options (in dollars per share) \| $ / shares	9.60
Maximum \| $10.50 - $10.80
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Weighted average price of outstanding options (in dollars per share) \| $ / shares	10.80
Maximum \| $14.20 - $23.40
Share-based Compensation, Shares Authorized under Stock Option Plans, Exercise Price Range [Line Items]
Weighted average price of outstanding options (in dollars per share) \| $ / shares	$ 23.40

Stockholders' equity - Additional Information (Details) - USD ($)	6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Dec. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation	$ 456,716	$ 120,089
Weighted average fair value of stock options granted (in dollars per share)	$ 2.21
Intrinsic value of options outstanding	$ 303,780		$ 0
Intrinsic value of options exercisable	$ 139,305		$ 0
Employee Stock Option
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Period of recognition	1 year
Share-based compensation	$ 272,401	$ 106,425
Unearned share-based compensation expense	$ 331,829

Related Party Collaboration Agreement (Details) - Intrexon Corporation - ECC Agreement - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2019	Jun. 30, 2018	Jun. 30, 2019	Jun. 30, 2018	Dec. 31, 2018
Accounts Payable and Accrued Liabilities
Related Party Transaction [Line Items]
Accounts payable and accrued liabilities due to related party	$ 2,594		$ 2,594		$ 800
Research and Development Expense
Related Party Transaction [Line Items]
Service costs incurred	$ 4,924	$ 44,893	$ 15,734	$ 136,041